A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1

作者: Chiori Yabuki , Hidetoshi Komatsu , Yoshiyuki Tsujihata , Risa Maeda , Ryo Ito

DOI: 10.1371/JOURNAL.PONE.0076280

关键词:

摘要: Selective free fatty acid receptor 1 (FFAR1)/GPR40 agonist fasiglifam (TAK-875), an antidiabetic drug under phase 3 development, potentiates insulin secretion in a glucose-dependent manner by activating FFAR1 expressed pancreatic β cells. Although significantly improved glycemic control type 2 diabetes patients with minimum risk of hypoglycemia study, the precise mechanisms its potent pharmacological effects are not fully understood. Here we demonstrate that acts as ago-allosteric modulator partial agonistic activity for FFAR1. In both Ca2+ influx and assays using cell lines mouse islets, showed positive cooperativity ligand γ-linolenic (γ-LA). Augmentation glucose-induced fasiglifam, γ-LA, or their combination was completely abolished islets FFAR1-knockout mice. diabetic rats, insulinotropic effect suppressed reduction plasma (FFA) levels lipolysis inhibitor, suggesting release conjunction FFAs vivo. Point mutations differentially affected activities further indicating these agonists may bind to distinct binding sites. Our results strongly suggest is exerts acting cooperatively endogenous human well animals. These findings contribute our understanding attractive novel mechanism action.

参考文章(43)
Masato Takeuchi, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tatsuya Hirano, Takayoshi Suzuki, Naoki Miyata, Takeo Awaji, Masaji Ishiguro, Gozoh Tsujimoto, FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models. British Journal of Pharmacology. ,vol. 168, pp. 1570- 1583 ,(2013) , 10.1111/J.1476-5381.2012.02052.X
Noel G Morgan, Fatty acids and β-cell toxicity Current Opinion in Clinical Nutrition and Metabolic Care. ,vol. 12, pp. 117- 122 ,(2009) , 10.1097/MCO.0B013E328321E423
Daniel C.-H. Lin, Jane Zhang, Run Zhuang, Frank Li, Kathy Nguyen, Michael Chen, Thanhvien Tran, Edwin Lopez, Jenny Ying Lin Lu, Xiaoyan Nina Li, Liang Tang, George R. Tonn, Gayathri Swaminath, Jeff D. Reagan, Jin-Long Chen, Hui Tian, Yi-Jyun Lin, Jonathan B. Houze, Jian Luo, AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0027270
Chi Shing Sum, Irina G. Tikhonova, Susanne Neumann, Stanislav Engel, Bruce M. Raaka, Stefano Costanzi, Marvin C. Gershengorn, Identification of Residues Important for Agonist Recognition and Activation in GPR40 Journal of Biological Chemistry. ,vol. 282, pp. 29248- 29255 ,(2007) , 10.1074/JBC.M705077200
Jian Luo, Gayathri Swaminath, Sean P Brown, Jane Zhang, Qi Guo, Michael Chen, Kathy Nguyen, Thanhvien Tran, Lynn Miao, Paul J Dransfield, Marc Vimolratana, Jonathan B Houze, Simon Wong, Maria Toteva, Bei Shan, Frank Li, Run Zhuang, Daniel C-H Lin, None, A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents PLoS ONE. ,vol. 7, pp. e46300- ,(2012) , 10.1371/JOURNAL.PONE.0046300
Christopher J. Langmead, Arthur Christopoulos, Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox Trends in Pharmacological Sciences. ,vol. 27, pp. 475- 481 ,(2006) , 10.1016/J.TIPS.2006.07.009
Irina G. Tikhonova, Chi Shing Sum, Susanne Neumann, Craig J. Thomas, Bruce M. Raaka, Stefano Costanzi, Marvin C. Gershengorn, Bidirectional, iterative approach to the structural delineation of the functional "chemoprint" in GPR40 for agonist recognition. Journal of Medicinal Chemistry. ,vol. 50, pp. 2981- 2989 ,(2007) , 10.1021/JM0614782
T. Araki, M. Hirayama, S. Hiroi, K. Kaku, GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. ,vol. 14, pp. 271- 278 ,(2012) , 10.1111/J.1463-1326.2011.01525.X
A Vaag, P Skött, P Damsbo, M A Gall, E A Richter, H Beck-Nielsen, Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation. ,vol. 88, pp. 1282- 1290 ,(1991) , 10.1172/JCI115432
ROBERT SUTTON, MAUREEN PETERS, PHILIP MCSHANE, DEREK W. R. GRAY, PETER J. MORRIS, Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation. ,vol. 42, pp. 689- 690 ,(1986) , 10.1097/00007890-198612000-00022